Overview

Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents

Status:
Terminated
Trial end date:
2016-09-28
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the absorption of a prepared aprepitant oral suspension with that of the aprepitant capsule in children being treated with chemotherapy agents that are likely to cause vomiting.
Phase:
Phase 2
Details
Lead Sponsor:
The Hospital for Sick Children
Treatments:
Aprepitant
Fosaprepitant